Marcus W Dercksen
Overview
Explore the profile of Marcus W Dercksen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brook T, Seetsen T, Dercksen M, van Riel A, Derleyn V, van den Bosch J, et al.
Oncologist
. 2024 Jun;
29(10):e1386-e1395.
PMID: 38869252
Background: Chemotherapy-induced alopecia is a common consequence of cancer treatment with a high psychological impact on patients and can be prevented by scalp cooling (SC). With this multi-center patient series,...
2.
Geurts S, Ibragimova K, Ding N, Meegdes M, Erdkamp F, Heijns J, et al.
Breast Cancer Res Treat
. 2024 Feb;
205(2):287-302.
PMID: 38381274
Purpose: The aim was to determine whether the real-world first-line progression-free survival (PFS) of patients diagnosed with de novo human epidermal growth factor receptor 2 positive (HER2+) advanced breast cancer...
3.
Ibragimova K, Geurts S, Laczko D, Meegdes M, Erdkamp F, Heijns J, et al.
Clin Breast Cancer
. 2023 Nov;
24(2):103-111.
PMID: 38007349
Background: This study aims to explore whether first-line pertuzumab use modifies the effect of prior use of (neo-) adjuvant trastuzumab on the PFS of first-line HER2-targeted therapy in patients with...
4.
Ibragimova K, Geurts S, Meegdes M, Erdkamp F, Heijns J, Tol J, et al.
Breast Cancer Res Treat
. 2023 Jan;
198(2):239-251.
PMID: 36635428
Purpose: We assessed the systemic treatment choices and outcomes in patients diagnosed with human epidermal growth factor receptor-2-positive (HER2 +) advanced breast cancer (ABC), for the first four lines of...
5.
Polee I, Hermans B, van der Zwan J, Bouwense S, Dercksen M, Eskens F, et al.
Eur J Cancer
. 2022 Jul;
172:252-263.
PMID: 35803176
Background: Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) comprise a group of rare malignant tumours with heterogeneous behaviour. This study aimed to assess long-term survival and prognostic factors associated with survival, in...
6.
van Riet J, van de Werken H, Cuppen E, Eskens F, Tesselaar M, van Veenendaal L, et al.
Nat Commun
. 2021 Jul;
12(1):4612.
PMID: 34326338
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and genetically heterogeneous malignancies, characterized by distinct prognoses based upon primary tumor localization, functionality, grade, proliferation index and diverse outcomes to treatment....
7.
Ibragimova K, Geurts S, Croes S, Erdkamp F, Heijns J, Tol J, et al.
Breast Cancer Res Treat
. 2021 Mar;
188(2):571-581.
PMID: 33743103
Purpose: Immediate and proper implementation of a new and more potent therapy is important to ensure that the patient achieves the best possible outcome. This study aimed to examine whether...
8.
Vleut R, van Poppel J, Dercksen M, Peerbooms M, Houterman S, Breed W
Support Care Cancer
. 2013 Jan;
21(7):1807-14.
PMID: 23338231
Purpose: In order to evaluate the efficacy of scalp cooling for the prevention of chemotherapy-induced alopecia (CIA), it is essential to precisely quantify the amount of hair mass that is...
9.
Hendriks M, Geerts P, Dercksen M, Van Den Hurk C, Breed W
Dermatol Surg
. 2012 Jan;
38(4):631-4.
PMID: 22268669
Background: Until now, there has been no reliable, simple method available for measuring hair quantity that is suitable in clinical practice. Recently, the cross-section trichometer by Cohen has been introduced....
10.
van de Poll-Franse L, Houterman S, Janssen-Heijnen M, Dercksen M, Coebergh J, Haak H
Int J Cancer
. 2007 Jan;
120(9):1986-92.
PMID: 17230509
The purpose of this study was to document the prevalence of diabetes among newly diagnosed cancer patients and to evaluate the influence of diabetes on stage at diagnosis, treatment and...